While the current deal with CMS allows eHealth, Inc. (NASDAQ:EHTH) to only market insurance plans that participate in the federally operated health exchanges, it’s still a tremendous victory for the company. With this win, eHealth, Inc. (NASDAQ:EHTH) is pushing hard to pick up business from some of the state exchanges.
Best of the best
My view is that Synta Pharmaceuticals Corp. (NASDAQ:SNTA) should do well with ganetespib. I wouldn’t be surprised to see the stock climb to above $10 per share from its Friday closing price of $6.43 over the next year or so.
I’m a little more reserved on eHealth, Inc. (NASDAQ:EHTH), but only because I’m not sure how many individuals will actually purchase Obamacare insurance plans. If optimists are correct, eHealth shares should keep marching upward. For now, my stance is to wait and see.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) and/or eHealth could do well, but Questcor Pharmaceuticals Inc (NASDAQ:QCOR) stands out as my favorite of this week’s humongous performers. The company isn’t dependent on how well clinical trials go, as Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is. Questcor Pharmaceuticals Inc (NASDAQ:QCOR)’s success has been achieved by solid execution of a smart business model.
Even with this week’s huge gains, Questcor Pharmaceuticals Inc (NASDAQ:QCOR)’s price/earnings-to-growth, or PEG, ratio stands at only 0.58. That’s really low. If Acthar sales continue to grow as I suspect they will, this stock still has plenty of room to run.
The article 3 Humongous Health-Care Stocks This Week originally appeared on Fool.com is written by Keith Speights.
Fool contributor Keith Speights and The Motley Fool have no position in any of the stocks mentioned.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.